The nomogram was used to predict the 1-, 2-, and 3-year OS of patients with newly diagnosed MM, based on five independent risk factors: age at diagnosis, clonal BM plasma cells, serum LDH, serum β2-microglobulin, and del (17p). This evidence concerns the gene HLA-G and Miyoshi myopathy.